Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 35 (1), 17-22
- https://doi.org/10.3109/02841869609098474
Abstract
The aim of the present study was to compare oestrogen receptor (ER) analysis results obtained in cytosols of frozen breast cancer tissue (using biochemical assay) with those obtained in paraffin-embedded tissue (using immunoperoxidase staining with monoclonal antibodies (DAKO-ER, 1D5), and an ER positivity cut-off level of > 10% stained nuclei). In 86% (84/98) of the samples the same ER status (28 negative and 56 positive) was obtained with both procedures. In eight cases, the paraffin section was ER positive but the corresponding cytosol sample ER negative, whereas six cases showed the opposite pattern. The ER positive subgroup manifested better outcome after adjuvant treatment than the ER negative subgroup (p = 0.003 (cytosol), and p = 0.004 (paraffin)). As compared with the percentage of stained nuclei, staining intensity yielded no additional information. Although the results of ER analysis of paraffin-embedded material seem promising, it is too early to prefer it to frozen tissue, though this would be useful when no frozen tissue is available.Keywords
This publication has 25 references indexed in Scilit:
- Immunocytochemical assay for estrogen receptor with monoclonal antibody d753pγ in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody h222Cancer, 1993
- Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.Journal of Clinical Pathology, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assaysEuropean Journal of Cancer and Clinical Oncology, 1990
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- Prognostic significance of estrogen and progesterone receptors in stage ii breast cancerJournal of Surgical Oncology, 1988
- The Stockholm trial on adjuvant tamoxifen in early breast cancerBreast Cancer Research and Treatment, 1987
- Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodiesBritish Journal of Cancer, 1986
- Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.Proceedings of the National Academy of Sciences, 1985
- BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUESThe Lancet, 1985